These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 11296164)

  • 1. Evaluation of salmeterol or montelukast as second-line therapy for asthma not controlled with inhaled corticosteroids.
    Wilson AM; Dempsey OJ; Sims EJ; Lipworth BJ
    Chest; 2001 Apr; 119(4):1021-6. PubMed ID: 11296164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additive bronchoprotective and bronchodilator effects with single doses of salmeterol and montelukast in asthmatic patients receiving inhaled corticosteroids.
    Dempsey OJ; Wilson AM; Sims EJ; Mistry C; Lipworth BJ
    Chest; 2000 Apr; 117(4):950-3. PubMed ID: 10767223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose reduction of inhaled corticosteroids under concomitant medication with montelukast in patients with asthma.
    Kanniess F; Richter K; Janicki S; Schleiss MB; Jörres RA; Magnussen H
    Eur Respir J; 2002 Nov; 20(5):1080-7. PubMed ID: 12449158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparisons of the complementary effect on exhaled nitric oxide of salmeterol vs montelukast in asthmatic children taking regular inhaled budesonide.
    Buchvald F; Bisgaard H
    Ann Allergy Asthma Immunol; 2003 Sep; 91(3):309-13. PubMed ID: 14533665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salmeterol powder provides significantly better benefit than montelukast in asthmatic patients receiving concomitant inhaled corticosteroid therapy.
    Fish JE; Israel E; Murray JJ; Emmett A; Boone R; Yancey SW; Rickard KA
    Chest; 2001 Aug; 120(2):423-30. PubMed ID: 11502639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of montelukast on surrogate inflammatory markers in corticosteroid-treated patients with asthma.
    Currie GP; Lee DK; Haggart K; Bates CE; Lipworth BJ
    Am J Respir Crit Care Med; 2003 May; 167(9):1232-8. PubMed ID: 12456382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
    Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA
    Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
    Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S
    Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial.
    Lazarus SC; Boushey HA; Fahy JV; Chinchilli VM; Lemanske RF; Sorkness CA; Kraft M; Fish JE; Peters SP; Craig T; Drazen JM; Ford JG; Israel E; Martin RJ; Mauger EA; Nachman SA; Spahn JD; Szefler SJ;
    JAMA; 2001 May 23-30; 285(20):2583-93. PubMed ID: 11368732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluticasone alone or in combination with salmeterol vs triamcinolone in asthma.
    Baraniuk J; Murray JJ; Nathan RA; Berger WE; Johnson M; Edwards LD; Srebro S; Rickard KA
    Chest; 1999 Sep; 116(3):625-32. PubMed ID: 10492263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of add-on therapy to inhaled fluticasone propionate in children with asthma: residual volume and exhaled nitric oxide as outcome measures.
    Verini M; Peroni DG; Piacentini GL; Nicodemo A; Rossi N; Bodini A; Chiarelli F; Boner AL
    Allergy Asthma Proc; 2007; 28(6):691-4. PubMed ID: 18201433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.
    Knorr B; Franchi LM; Bisgaard H; Vermeulen JH; LeSouef P; Santanello N; Michele TM; Reiss TF; Nguyen HH; Bratton DL
    Pediatrics; 2001 Sep; 108(3):E48. PubMed ID: 11533366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the effects of oral montelukast and inhaled salmeterol on response to rescue bronchodilation after challenge.
    Storms W; Chervinsky P; Ghannam AF; Bird S; Hustad CM; Edelman JM;
    Respir Med; 2004 Nov; 98(11):1051-62. PubMed ID: 15526805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma.
    D'Alonzo GE; Nathan RA; Henochowicz S; Morris RJ; Ratner P; Rennard SI
    JAMA; 1994 May; 271(18):1412-6. PubMed ID: 7909853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addition of leukotriene antagonists to therapy in chronic persistent asthma: a randomised double-blind placebo-controlled trial.
    Robinson DS; Campbell D; Barnes PJ
    Lancet; 2001 Jun; 357(9273):2007-11. PubMed ID: 11438132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A fixed combination of fluticasone and salmeterol permits better control of asthma than a beclomethasone dipropionate and montelukast combination].
    Grosclaude M; Cerruti JL; Delannay B; Hérent M; Spilthooren F; Desfougères JL
    Eur Ann Allergy Clin Immunol; 2003 Nov; 35(9):356-62. PubMed ID: 14716965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol.
    Kalra S; Swystun VA; Bhagat R; Cockcroft DW
    Chest; 1996 Apr; 109(4):953-6. PubMed ID: 8635376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addition of montelukast or salmeterol to fluticasone for protection against asthma attacks: a randomized, double-blind, multicenter study.
    Ilowite J; Webb R; Friedman B; Kerwin E; Bird SR; Hustad CM; Edelman JM
    Ann Allergy Asthma Immunol; 2004 Jun; 92(6):641-8. PubMed ID: 15237766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential masking effects of salmeterol on airway inflammation in asthma.
    Mcivor RA; Pizzichini E; Turner MO; Hussack P; Hargreave FE; Sears MR
    Am J Respir Crit Care Med; 1998 Sep; 158(3):924-30. PubMed ID: 9731027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of Asthma in School age Children On Therapy (MASCOT): a randomised, double-blind, placebo-controlled, parallel study of efficacy and safety.
    Lenney W; McKay AJ; Tudur Smith C; Williamson PR; James M; Price D;
    Health Technol Assess; 2013 Feb; 17(4):1-218. PubMed ID: 23380178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.